A proprietary drug delivery platform that uses human Alpha-Fetoprotein (AFP) to deliver selective chemotherapy, avoiding damage to normal cells.
There’s no risk. Start your trial today to see profiles of Alpha Cancer Technologies (aka ACT) plus 5597 other startups.
Start Free 7 Day Trial Now